Storia in 2 fonti

AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants

Raccontata da

benzinga.com

morningstar.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

morningstar.comStai leggendo13 h fa

AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded…

AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants

originale

benzinga.com1 g fa

What's Going on With AbCellera Biologics Stock On Wednesday? - AbCellera Biologics (NASDAQ:ABCL)

AbCellera raised $200M; lead program ABCL635 hit new efficacy benchmark for menopausal symptoms. Positive trial data + capital boost fuel 136% YoY momentum and analyst upgrades ($30 targets), signaling strong market confidence in its therapeutic pipeline.

Leggi questa versione →

Timeline cronologica

mercoledì 12 agosto 2026·benzinga.com
What's Going on With AbCellera Biologics Stock On Wednesday? - AbCellera Biologics (NASDAQ:ABCL)
AbCellera shares rise after positive ABCL635 Phase 2 results, while bullish momentum and analyst price targets point to further upside.
giovedì 13 agosto 2026·morningstar.com
AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants
AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants